European Archives - Page 204 of 1176 - European Medical Journal

Efficacy of High-Dose Vitamin D for Overactive Bladder Dry

High-dose vitamin D supplementation significantly improves voiding frequency and other symptoms in children with overactive bladder

Prenatal Exposure to Phenols Linked to Increased Asthma Risk in Children

Prenatal exposure to common phenols, including butylparaben, has been linked to an increased risk of asthma in children, particularly among boys, according to a large-scale study from Japan.

Brain Imaging Reveals Key Changes in Opioid Use Disorder Patients: RSNA 2024

Imaging methods reveal brain alterations caused by opioid use.

New Insights into Depression: Skull Bone Marrow, Sinuses, and Inflammation

Imaging reveals how skull regions mediate brain-periphery immune crosstalk in depression, uncovering new therapeutic targets.

Dark Chocolate Linked to Lower Risk of Type 2 Diabetes

Consuming dark chocolate linked to reduced risk of type 2 diabetes, study finds.

Gut Microbiome Modulation: Transforming Melanoma Immunotherapy

Fibre-rich diets promote beneficial microbiota, producing short-chain fatty acids that enhance immune functions.

The Role of Biomarkers in Frailty and Liver Health

Frailty has emerged as a therapeutic target in advanced chronic liver disease management, with non-pharmacological interventions showing promise.

Long-Term Success with Cyclophosphamide in Refractory Myasthenia Gravis

Cyclophosphamide offers rapid remission and long-term benefits in high-risk myasthenia gravis, reducing corticosteroid reliance and injectable therapies.

Obesity Linked to More Severe Symptoms and Higher Steroid Use in Polymyalgia Rheumatica

Obesity may worsen symptoms and increase glucocorticoid requirements in polymyalgia rheumatica, according to new research. Patients with obesity reported greater pain and fatigue and needed higher steroid doses over time despite similar inflammation levels.

Mifepristone-Misoprostol Reduces Treatment Failure in Early Pregnancy Loss

The addition of mifepristone to misoprostol for medical management of early pregnancy loss significantly reduces the rate of treatment failure.